openPR Logo
Press release

Global Ischemic Optic Neuropathy Treatment Market 2022: Covering Historic Growth of Market and Forecasting the Future 2031

07-06-2022 05:24 PM CET | Health & Medicine

Press release from: Persistence Market Research

Global Ischemic Optic Neuropathy Treatment Market 2022:

Ischemic optic neuropathy occurs because of a small vessel infraction of the optic nerve, and is a significant reason for impaired vision or blindness. Increasing utilization of newly approved intravitreal implants for the treatment of optic nerve disorders is expected to drive the market over the coming years.

With developing awareness toward eye-associated inconveniences that give rise to impaired vision, diabetic patients and the geriatric population in developed nations are believed to have a proactive methodology for treatment-associated difficulties instead of reactive treatment, which likewise supports the development of the market.

Drug manufacturing and leading pharmaceutical companies from emerging nations are significantly investing in research & development activities, new technologies, and infrastructure in ophthalmology therapeutics to capture a market share in the developing burden of eye infections.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/23077

According to a new report published by Persistence Market Research, the global ischemic optic neuropathy treatment market valued at US$ 187.7 Mn in 2020, and is predicted to expand at a CAGR of close to 4% over the forecast period (2021-2031).

Company Profiles:

AbbVie Inc.
Eli Lily Company
GlaxoSmithKline
Pfizer Inc.
Teva Pharmaceuticals
Bausch Health Companies Inc.
F. Hoffmann-La Roche AG
Bayer AG
Sanofi A.S.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/23077

Key Takeaways from Market Study

Anticoagulants are expected to contribute over 47% revenue share in the market by 2031.

Anterior ischemic optic neuropathy is expected to account for more than 75% of the global market share. These neuropathies contribute 90% of the total ischemic optic neuropathies that occur worldwide.

Oral route is the most preferred route of administration, and is expected to dominate the market with a share of over 71% by 2031.

Among all the distribution channels, retail pharmacies accounted for more than 45% of the market share in 2020.

North America holds the highest share in the global market for ischemic optic neuropathy treatment, owing to availability of advanced treatment facilities and medical infrastructure for ischemic optic neuropathy treatment in the country.

The U.S. holds a big portion of global revenue, and accounts for more than 90% share in the North American market.

Key players are focused on strengthening their clinical pipelines through discoveries of novel abuse-deterrent formulations.

"Technological advancements in ischemic optic neuropathy treatment, increasing prevalence of optic nerve disorders, rising geriatric population, and increasing research & development activities are is expected to drive market growth over the coming years," says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/23077

Increasing R&D Spending by Pharmaceutical Companies

Major pharmaceutical companies are aiming at developing improved drugs for ischemic optic neuropathy management. Moreover, few manufacturers are solely focusing on the development of drugs for the treatment of ischemic optic neuropathy with minimum side-effects.

Thus, increasing spending by leading pharmaceutical companies for the development of drugs with minimum side-effects is expected to propel market expansion over the forest period.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the ischemic optic neuropathy treatment market in its latest study, presenting a historical demand assessment of 2016 - 2020 and projections for 2021 - 2031.

The research study is based on drug class (corticosteroids, antimetabolites, anticoagulants, serotonin and norepinephrine reuptake inhibitors (SNRIs), and nonsteroidal anti-inflammatory drugs (NSAIDs)), route of administration (oral and injectable), disease (anterior ischemic optic neuropathy and posterior ischemic optic neuropathy), and distribution channel (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies), across seven key regions of the world.

Access PMR Exclusive Reports-

Crushed Red Pepper Market- https://www.persistencemarketresearch.com/market-research/crushed-red-pepper-market.asp

Dried Fruits Market- https://www.persistencemarketresearch.com/market-research/dried-fruits-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Ischemic Optic Neuropathy Treatment Market 2022: Covering Historic Growth of Market and Forecasting the Future 2031 here

News-ID: 2673209 • Views: 188

More Releases from Persistence Market Research

The Next Upcoming Years To See The Mineral Salt Ingredients Market Get Through T …
Persistence Market Research delivers key insights on the global mineral salt ingredients market in a newly published report titled "Mineral Salt Ingredients Market: Global Industry Analysis and Forecast, 2016 - 2024." In terms of revenue, the global mineral salt ingredients market is estimated to register a promising CAGR of 5.1% over the forecast period, owing to numerous factors, about which Persistence Market Research offers thorough insights and forecasts in this
The Industrial Fat Fraction Market To Grow With Rightsized Innovation Between 20 …
Persistence Market Research (PMR) has published a new report on the industrial fat fraction market titled "Industrial Fat Fraction Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025." The rising consumption of dairy products is fueled by the nutritional benefits associated with the consumption of these products. As per the Food and Agriculture Organization (FAO), approximately 150 million households are engaged in milk consumption at a
The Next Upcoming Years To Move Beyond Clichéd Roadmap With Innovations Between …
Increasing demand for white chocolates in food and beverage industry and cosmetics sector continues to be a key driving factor for the growth of the market. The various features of white chocolate, such as skin hydration, rich, variable textures, and superior taste is driving demand for white chocolates in the F&B, and cosmetics industry. Key market players such as Mars Incorporated, GCPPL Ltd., Nestle SA, Ghirardelli Chocolate Co., Mondelez International, Chocolatiers
The Casein Caseinate Market To Witness An Illustrious Growth Amidst Innovation B …
According to a new market report published by Persistence Market Research "Global Market Study on Casein and Caseinate: Industrial casein to be the Largest Sub-segment by 2025", the global casein & caseinate market was valued at US$ 2143.1 Mn in 2014 and is expected to expand at a CAGR of 4.7% to account for US$ 3564.4 Mn by 2025. The global casein & caseinate market is segmented on the basis

All 5 Releases